About vinorelbine
Vinca alkaloid chemotherapy medicine
Used for
- Treats non-small-cell lung cancer
- Treats advanced breast cancer
Usual adult dose
Usually 25–30 mg/m² intravenously once weekly; schedules vary by cancer and combination.
Common side effects
- Low blood cell counts
- Nausea, vomiting, constipation
- Hair loss
- Injection-site irritation
Important warnings
- Can cause severe infection or bleeding from low blood counts.
- Requires regular blood tests and specialist supervision.
- Avoid contact with skin or eyes; leakage can damage tissue.
- Can cause fetal harm; effective contraception is required.
Pregnancy
Can harm an unborn baby. Avoid during pregnancy unless specialist-directed; contraception is advised during treatment and afterward.
Breastfeeding
Breastfeeding is not recommended during treatment.
Interactions
- Strong CYP3A inhibitors or inducers can alter vinorelbine levels.
- Other medicines that suppress bone marrow increase infection and bleeding risks.
- Live vaccines may cause serious infection during treatment.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.